How Kiniksa Pharmaceuticals International, plc stacks up

KNSA · against 196 other Healthcare companies of similar size

Ranking by overall score

Top 5 and the companies ranked around KNSA

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	RemeGen Co., Ltd.9995.HK · Hong Kong	37.3B HKD (≈$4.8B)	90	99	98	84	0 / 2
2	Lupin LimitedLUPIN.NS · India	921.9B INR (≈$11.1B)	82	84	80	94	0 / 2
3	Asahi Intecc Co., Ltd.7747.T · Japan	936.1B JPY (≈$6.4B)	80	65	86	94	0 / 2
4	Camurus AB (publ)CAMX.ST · Europe	40.3B SEK (≈$4.0B)	79	43	84	97	0 / 2
5	Globus Medical, Inc.GMED · US-listed	10.7B USD	78	77	85	84	0 / 2
⋯
10	ALTEOGEN Inc.196170.KQ · South Korea	14.87T KRW (≈$10.7B)	76	37	97	94	0 / 2
12	Ono Pharmaceutical Co., Ltd.4528.T · Japan	1.09T JPY (≈$7.4B)	75	93	54	78	0 / 2
13	M3, Inc.2413.T · Japan	1.21T JPY (≈$8.2B)	74	72	72	85	1 / 2
13	BillionToOne, Inc.BLLN · US-listed	5.2B USD	74	37	—	91	0 / 2
13	Kiniksa Pharmaceuticals International, plcKNSA · US-listed	7.3B USD	74	40	97	81	0 / 2
13	Protagonist Therapeutics, Inc.PTGX · US-listed	9.1B USD	74	38	83	83	0 / 2
17	Ajanta Pharma LimitedAJANTPHARM.NS · India	414.8B INR (≈$5.0B)	73	55	66	93	0 / 2
17	Ipsen S.A.IPN.PA · Europe	12.6B EUR (≈$13.9B)	73	85	57	92	1 / 2
19	China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.000999.SZ · China	43.1B CNY (≈$6.0B)	72	89	66	76	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score